Insider Transactions in Q1 2026 at Kymera Therapeutics, Inc. (KYMR)

KYMR Quotes by TradingView

Insider Transaction List (Q1 2026)

Date Insider Transaction Ownership Type Shares Traded Value / Price
Jan 05 2026
Nello Mainolfi Chief Executive Officer
BUY
Exercise of conversion of derivative security
Direct
3,118 +0.47%
$99,776 $32.07 P/Share

Track Institutional and Insider Activities on KYMR

Follow Kymera Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KYMR shares.

Notify only if

Insider Trading

Get notified when an Kymera Therapeutics, Inc. insider buys or sells KYMR shares.

Notify only if

News

Receive news related to Kymera Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KYMR